ArticleThe journal of allergy and clinical immunology. In practice2025

Direct oral challenges safely reduce the burden of low-risk cephalosporin allergy labels.

Jason Moraczewski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.